Biden Orders Feds to Target Health Care Consolidation but Deals Continue by Glenn S. Demby | Aug 16, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here
23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition by Glenn S. Demby | Jul 11, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here
PerkinElmer Turns COVID Cash into Acquisitions While Myriad Genetics Keeps Divesting by Glenn S. Demby | Jun 14, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here
Thermo Fisher, Siemens Healthineers and DiaSorin Headline a Super Dynamic Month in Deal Making by Glenn S. Demby | May 19, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here
Antitrust Regulators Derail Plans for Illumina-Grail Cancer Genomics Powerhouse by Glenn S. Demby | May 6, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here